Tengjun Biotechnology Corp. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 9,669 compared to USD 7,600 a year ago. Net loss was USD 15,678 compared to USD 12,900 a year ago. For the half year, operating loss was USD 20,998 compared to USD 18,951 a year ago. Net loss was USD 32,482 compared to USD 29,690 a year ago.